Company Filing History:
Years Active: 2014
Title: Xiuhui E: Innovator in Diabetes Treatment
Introduction
Xiuhui E is a prominent inventor based in Tianjin, China. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes. His innovative work has led to the development of a unique pharmaceutical composition aimed at managing diabetes mellitus.
Latest Patents
Xiuhui E holds a patent for a pharmaceutical composition for treating diabetes and its process for preparation. The invention relates to methods for preparing a pharmaceutical composition that includes extracts from various crude drugs. The composition comprises 5-40 weight parts of Tianhuafen, 10-30 weight parts of Chaihu, 3-15 weight parts of Zhishi, 1-6 weight parts of Dahuang, 1-12 weight parts of Banxia, 3-15 weight parts of Huangqin, 1-12 weight parts of Huanglian, 3-15 weight parts of Baishao, and 5-20 weight parts of Wumei. Additionally, it may optionally include pharmaceutically acceptable excipients and can further comprise Shanzha. The invention also discloses four methods for preparing the pharmaceutical composition.
Career Highlights
Xiuhui E is associated with Tasly Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical industry. His work at Tasly has been instrumental in advancing diabetes treatment options. He has a total of 1 patent to his name, showcasing his innovative contributions to healthcare.
Collaborations
Xiuhui E has collaborated with notable colleagues, including Xiaolin Tong and Yonghong Zhu. Their combined expertise has further enhanced the research and development efforts within the company.
Conclusion
Xiuhui E's innovative work in developing a pharmaceutical composition for diabetes treatment highlights his significant role in the field of medicine. His contributions continue to impact the lives of those affected by diabetes, showcasing the importance of innovation in healthcare.